Camargo Pharmaceutical Services LLC, a company that provides drug development services, has named Jennie Orr as its new chief strategy and business officer, it was reported on Tuesday.
In the new role, Orr is to head the company's development, communication and execution of corporate strategic growth initiatives, including both organic growth and its mergers and acquisitions activities.
Orr heads the company's Corporate Development and Operational Excellence functions. She has around 20 years of life sciences industry experience, in various business development and strategy roles. She is a strategy consultant with the Monitor Group.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer